Certain Balance Sheet Accounts - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Intangible assets, net	$ 2,325,000		$ 2,325,000		$ 1,696,000
Accumulated amortization	473,000		473,000		329,000
Capitalized software development costs	1,873,000		1,873,000		1,101,000
Capitalized computer software, amortization			0	$ 0
Impairment of intangible assets, finite-lived	41,000		41,000
Accrued sales return current	$ 8,897,000		$ 8,897,000		21,179,000
Preferred stock authorized (in shares)	100,000,000		100,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001		$ 0.0001
Preferred stock outstanding (in shares)	0		0
Customers For Which Returns Are Expected To Be Received
Property, Plant and Equipment [Line Items]
Accrued sales returns resulting from FDA Warning Letter	$ 6,843,000		$ 6,843,000		$ 20,145,000
Tooling and manufacturing equipment
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	210,000	$ 160,000	608,000	457,000
Property and Equipment
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	$ 332,000	$ 253,000	$ 966,000	$ 691,000